Queensland life sciences
clinical trials directory

PRAXIS Australia is leading national and international education and training provider of high-quality, relevant and accessible training to build the confidence and capability of those working in clinical trials, research and ethics. Their offers have been built upon Harvard Multi-Regional Trials Centre competencies and aligned to NHMRC competencies. These training offers are a benchmark for research and clinical trials professionals in Australia, New Zealand, Asia Pacific Region, Europe, and the United States.

The leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy.

The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.

We are a global drug development accelerator with over 1,300 staff operating from state-of-the-art development, manufacturing and clinical testing facilities in the U.S. and U.K. We have over 30 years of experience and have worked on over 3,000 molecules across all stages of development.

Coral Sea Clinical Research Institute is a clinical research facility in Northern Queensland. Specialising in Phase II and III Gastroenterology trials, Coral Sea Clinical Research Institute work alongside a team of leading, internationally recognised Gastroenterologists to deliver high quality clinical trials. At Coral Sea Clinical Research Institute, our core mission is to enable patients living in regional Queensland to have access to clinical trial therapies.

The Gold Coast Health and Knowledge Precinct is a global business destination recognised for transforming lives through healthcare innovation, new knowledge and next-generation technologies.

CROW Clinical is a full service and tailorable Clinical Research Organization servicing Australia and New Zealand. We are the only CRO that offers a dedicated team of Field Clinical Engineers. We specialize in high tech medical device start ups and CROW Clinical is the experts for Med Tech and Biotech clinical trials. We pride ourselves on tailoring a specific service, so you only pay for exactly what you need. We are a premier Clinical Research Organization without the huge price tag.

NuNerve Pty Ltd collaborates with scientists from the University of Queensland to develop a drug candidate for treating motor neurone disease (MND). The drug blocks the EphA4 protein, which plays a crucial role in motor neuron guidance and inhibiting their recovery after injury. This discovery has implications for MND, spinal cord injury, and other neurological diseases, offering a potential treatment for MND patients. NuNerve aims to manufacture the drug for upcoming clinical trials, prioritizing communication through healthcare professionals and providing updates via the QBI website and newsletter. Their urgent goal is to find a cure or disease-modifying strategy for MND.

Established in 1994 by a group of dedicated doctors, Wesley Research Institute is Queensland’s second-oldest medical research institute. Wesley Research Institute aims to improve patient outcomes by linking medical and health research to clinical outcomes.

WearOptimo is an Australian Healthtech company at the forefront of wearables and precision medicine. Our unique and patented Microwearable platform is designed to access and interpret key health signals continuously, remotely, and in real-time, while being unobtrusive and pain-free to the user.

Therapeutic Innovation Australia (TIA) provides a wide range of translational services. TIA works to lower the bar for researchers to access excellent translational research services in the fields of biologics, cell therapies, small molecules, preclinical testing and clinical trials.

USC Clinical Trials, in collaboration with healthcare professionals in the Sunshine Coast and Moreton Bay, offers expert services for all phases of drug and device clinical trials. They have a wide range of therapeutic areas in their expanding portfolio. The team comprises experienced Principal and Sub-Investigators who are matched to each study based on their expertise. With over 40 completed and ongoing studies across phases I to IV, USC Clinical Trials has the necessary experience to support your research.

Servatus BioPharmaceuticals Limited are a biopharmaceutical research and production company, based on the Sunshine Coast, Queensland. Established in 2012, we research, develop and produce high-quality, innovative, medical grade biopharmaceuticals based on the latest scientific research. Servatus has two drug research platforms: Engineered proteins for the treatment of autoimmune diseases, and microbial biotherapeutics for the treatment of inflammatory conditions and bacterial infections.

The Queensland Emory Drug Discovery Initiative (QEDDI) is a unique small molecule drug discovery and development group operating within an Australian university, UniQuest. Their mission is to bridge the gap between academic biomedical research and the development of new medicines. With an industry-experienced team, QEDDI focuses on advancing biomedical research into promising drug candidates to facilitate commercial partnerships and expedite drug development. They possess core capabilities and expertise in medicinal chemistry, compound screening, and profiling, enabling them to drive the discovery of innovative therapeutics.

Protagonist Therapeutics is a clinical-stage biopharmaceutical company. We strive to improve patients’ lives through the power of peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate.

Patheon Biologics, a division of Thermo Fisher Scientific, offers comprehensive pharmaceutical services to support the entire biotechnology and pharmaceutical life cycle. Thermo Fisher's pharma services solutions aid customers in accelerating innovation and enhancing productivity in drug development and commercialization. As a strategic contract development and manufacturing organization (CDMO) and clinical services partner, they serve the pharmaceutical, biotech, and life sciences industries. At their mammalian-based cGMP facility in Brisbane, Australia, Patheon supports clients in large-scale GMP manufacturing of biopharmaceuticals.

PharmaSols is the longest established, best connected, privately-owned Clinical Research Organisation (CRO) in the Pacific region. They have international experience with large pharmaceutical, medical device and biotech organisations, with expertise across a wide variety of therapeutic areas.

Microbio is an Australian biotechnology startup that aims to revolutionise pathogen detection with our unique, specific, sensitive and fast pathogen identification test. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology.

Nucleus Network's Brisbane facility, formerly known as Q-Pharm, is a dedicated clinical trial unit situated at the Royal Brisbane and Women's Hospital. As Australia's second-largest Phase 1 unit, it conducts clinical trials for companies and researchers involved in developing new, safer, and more effective medications. With over 15 years of reliable experience, Q-Pharm has successfully completed over 400 Early Phase studies and recruited over 15,000 participants. Specializing in early-phase (phases 1 and 2) clinical trials, Q-Pharm operates in a cutting-edge facility located in the Herston precinct at the Royal Brisbane and Women's Hospital in Brisbane, Australia.

QBiotics Group is dedicated to improving the lives of people and animals by discovering and creating transformational pharmaceuticals derived from nature. Our primary programmes are in oncology and wound healing.

KE Select is an Australian based, leading Scientific & Medical Recruitment Partner for organisations within the Life Science, Medical, Clinical, Hospital and Healthcare space. Director Kerry McMahon, BSc Biomedical Science has over 15 years’ experience carrying out Executive Search, Permanent and Contract based recruitment projects in ANZ and more recently into APAC. Kerry and her team are passionate about tailoring every client’s needs. The focus for KE Select is to build and maintain personal longterm relationships.

Microba is a microbial genomics company providing the public with access to cutting-edge technology to analyse their personal gut microbiome. Using one of the most advanced sequencing technologies, Microba empowers consumers to gain a deeper understanding of their personal microbiome.Microba's therapeutic discovery is generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome.

LuminaX has accelerated 21 Australian startups with $1.2M in direct capital through our VC partners and mentors network, provided connections to over 200 clinicians and experts, linked 9 startups with access to clinical trials and research projects, and supported raising another $2M post program.

Kira Biotech is an Australian biotech company focused on developing immunomodulatory compounds to treat immune system disorders. Their lead candidate, KB312, is a selective monoclonal antibody that depletes activated immune cells, aiming to restore immune balance and tolerance. With venture capital funding, Kira Biotech is advancing KB312 through preclinical development and phase 1 clinical trials. The company is led by renowned rheumatologist and immunologist, Dr. Dan Baker, along with a team of drug development experts.

Implicit Bioscience is a Brisbane- and Seattle-based biotech company developing a first-in-class biologic drug in the new field of immunoneurology. lead therapeutic candidate IC14 is an investigational anti-CD14 monoclonal antibodyIC14 regulates pathogenic inflammatory responses to infection and injury, and has great potential across a variety of disease areas. Right now, we are focused on testing its efficacy in the fight against Motor Neurone Disease (MND) or Amyotrophic lateral sclerosis (ALS), and Coronavirus (COVID-19).

Immunexpress is developing technology to accurately rule-in or rule-out sepsis in patients suspected of infection. Lack of reliable diagnostics leads to the over-treatment of sepsis, creating an overwhelming burden to healthcare systems, hospitals, clinicians, nurses, payers and antibiotic stewardship efforts. Our goal is to transform sepsis diagnostics by providing clinicians with the technology to rapidly enable and confidently make the right treatment decisions.

Icon Group operates Australia’s largest private cancer clinical trials program with a growing reach globally. provide patients and clinicians with access to national and international clinical trials across medical oncology, haematology and radiation oncology, as well as unique Icon Investigator-Initiated trials. Icon is proud to operate the largest Phase I clinical trials program and has continued to lead the way in first in-human trials helping to evolve the future of cancer treatments.

Clinical Network Services is an integrated service group based in Australia with global offices. They specialize in product development, supporting small to medium biotech companies by expediting their early-stage products through clinical trials and the marketplace. With BioDesk consultancy, they provide intelligent global product development and regulatory affairs support, combined with their experienced clinical services and biometrics team in Australia and New Zealand, offering a comprehensive and efficient service.

BioPharma Excellence by Pharmalex works closely with biopharma businesses, international regulators and health authorities, and potential investors, to confidently optimize the market potential of cutting-edge biotech innovation. Their team is a fusion of three scientific powerhouses, Pharmalex, ERA Consulting and Biopharma Excellence – under the PharmaLex brand. We combine 35+ years of empirical experience and respected regulator relationships.

Graphics et al. offers subscription software for creating scientifically accurate images and animations without the need for a graphic designer. Their user-friendly interface and extensive library of over 10,000 digital assets enable users to create visually stunning diagrams and automations quickly. Their mission is to simplify scientific communication for all users. They cater to various industries, including healthcare, clinical trials, scientific manufacturing, medtech, laboratory training, and research.

Griffith University's Clinical Trial Unit, located within the Gold Coast Health and Knowledge Precinct and adjacent to the Gold Coast University Hospital, provides state-of-the-art facilities and professional coordination services to phase I-IV clinical trials. Supporting university staff and collaborators to conduct a wide range of trials, but also offering professional clinical trial site services to commercial clients such as global pharma, contract research organisations and the biotech and nutraceutical industry.

Bellberry Limited is a national, private not-for-profit organisation providing streamlined scientific and ethical review of human research projects across Australia.

Clinials is an AI-Driven clinical trial participant recruitment platform. We help researchers and pharmaceutical companies find eligible and engaged participants for their trials. Born in Brisbane, Australia – the world’s test bed for clinical trials, Clinials has global experience with clinical trial recruitment. .

The Australian Institute for Bioengineering and Nanotechnology is an integrated multidisciplinary research institute bringing together world-class researchers and cutting-edge technology with a focus on translational research.

360biolabs is a contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics in a quality-assured environment. Diverse range of assays and biomarker endpoints for clinical trials and preclinical studies in many therapeutic areas Expertise in virology, immunology and analytical chemistry. World-class facilities with BSL-2, BSL-3 & quarantine laboratories > Quality management systems to ensure that “every sample counts”

The principal goal of Avatar is to provide specialist insurance broking services to companies that develop innovative technology. Our key advantage is objective, in-depth research on industry-specific exposures. Avatar acts for 36% of the ASX listed Pharmaceuticals, Biotechnology & Life Sciences sector. They are the market leader in placement for emerging risks70% of their client base is derived from technology, life sciences, green energy & related service providers.

Alliance Pharma is a Contract Research Organization (CRO) specializing in Drug Metabolism and Pharmacokinetics (DMPK) and bioanalytical services for both small and large molecules. It is our goal to help you through the process of taking your drug from pre-clinical/clinical trials to market as fast and as problem-free as possible.

AusTrials is a leading private clinical research organisation, with dedicated and managed research sites in Australia. We are leaders in delivering phase II-IV interventional studies, capturing real world evidence and conducting observational research in the usual clinical setting.

Beyond is an integrated product development team dedicated to early-stage product development, focusing primarily on advancing innovative products from small to medium biotechnology and pharmaceutical companies worldwide. As an Australian privately owned company, we provide flexible and nimble solutions to match the needs of our clients, whether it is a stand-alone activity or a full suite of services.